Source: FinanzNachrichten

BioInvent: BioInvent International: BioInvent to Participate in Upcoming Investor Conferences

LUND, SE / ACCESS Newswire / April 1, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-clas...

Read full article »
Annual Revenue
$25-100M
Employees
25-100
Martin Welschof's photo - President & CEO of BioInvent

President & CEO

Martin Welschof

CEO Approval Rating

92/100

Read more